O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Alabama at Birmingham

About this trial

The goal of this trial is to test if colonization with the gut bacteria Oxalobacter formigenes leads to a reduction in urinary oxalate excretion in patients with calcium oxalate kidney stone disease.

The study will recruit adult participants with a history of calcium oxalate kidney stones who are not colonized with Oxalobacter formigenes.

Participants will

* ingest fixed diets containing low and moderately high amounts of oxalate for 4 days at a time * collect urine, blood and stool samples during the fixed diets * ingest a preparation of live Oxalobacter formigenes to induce colonization with Oxalobacter formigenes

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age 19-80 yrs

Body Mass Index > 18.5 kg/m2

First time or recurrent Calcium Oxalate stone former. Composition of most recent stone ≥ 50% calcium oxalate if available

Not colonized with Oxalobacter formigenes

Disqualifiers

Chronic Kidney Disease stage 4-5

Primary hyperoxaluria

Liver, endocrine or renal diseases (other than idiopathic Calcium Oxalate kidney stones) or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results, including: Cystic fibrosis, Cystinuria, Uric acid stone former, Nephrotic syndrome, Sarcoidosis, Renal tubular acidosis, Primary hyperparathyroidism, Neurogenic bladder, Urinary diversion

Pregnancy or breast-feeding

Trial design

Design model

Sequential

Treatments tested in this trial

  • Low oxalate fixed diets pre-colonization

    Dietary supplement

    4 days of fixed eucaloric diet with low oxalate (\< 60 mg/day), normal calcium (600-1000 mg/day)

  • Moderately high oxalate fixed diets pre-colonization

    Dietary supplement

    4 days of fixed eucaloric diet with moderately high oxalate (250-300 mg/day), normal calcium (600-1000 mg/day)

  • Colonization with Oxalobacter formigenes

    Dietary supplement

    Ingestion of live Oxalobacter formigenes

  • Low oxalate fixed diets post-colonization

    Dietary supplement

    4 days of fixed eucaloric diet with low oxalate (\< 60 mg/day), normal calcium (600-1000 mg/day)

  • Moderately high oxalate fixed diets post-colonization

    Dietary supplement

    4 days of fixed eucaloric diet with moderately high oxalate (250-300 mg/day), normal calcium (600-1000 mg/day)

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: colonization with Oxalobacter formigenesExperimental treatment 5 interventions

Trial outcomes

Primary outcomes

1

Change in urinary oxalate excretion following colonization with Oxalobacter formigenes

Difference between urinary oxalate excretion on the moderately high oxalate diet pre-colonization and urinary oxalate excretion on the moderately high oxalate diet post-colonization

Time frame
2 months

Secondary outcomes

1

Sustainability of colonization with Oxalobacter formigenes

duration of colonization after successful induction of colonization sith Oxalobacter formigenes

Time frame
4 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alabama at Birmingham

Lead sponsor

University of Texas Southwestern Medical Center

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator